EX-99.1 2 tm2523710d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 US FDA Approval of PAPZIMEOS August 18, 2025 ────────────────────── 2 Forward-looking Statement This presentation contains “forward-looking” statements within the meaning of the safe harbor provisions of the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. These statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from what the Company expects. Examples of forward-looking statements include, among others, information relating to the Company’s business and business plans, the success of efforts to commercialize PAPZIMEOS (zopapogene imadenovec-drba) for the treatment of recurrent respiratory papillomatosis (RRP) in adults, the Company’s ability to successfully obtain foreign regulatory approvals for PAPZIMEOS, expectations about the safety and efficacy of PAPZIMEOS and the Company’s…
Open exhibit ↗Current Report · Items 7.01, 9.01 · 8-K
Precigen, Inc.
PGENNASDAQEQUITYCurrent
Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. Precigen, Inc. provided a slide presentation at a webcast investor conference held on August 18, 2025 at 8:00 AM Eastern Time. A copy of the presentation is attached hereto as Exhibit 99.1.…
Disclosure sections
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
Precigen, Inc. provided a slide presentation at a webcast investor
conference held on August 18, 2025 at 8:00 AM Eastern Time. A copy of the presentation is attached hereto as Exhibit 99.1.
This information, including the Exhibit attached hereto, shall
not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.